| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |